Durable remission in a patient of mixed phenotype acute leukemia with Philadelphia chromosome-positive treated with nilotinib and lenalidomide: A case report

RATIONALE: Philadelphia chromosome-positive mixed phenotype acute leukemia (Ph+ MPAL) is a rare type of leukemia with poor prognosis. Tyrosine kinase inhibitors (TKIs) in combination with chemotherapy have significantly improved its remission rate. However, relapse remains the major obstacle to achi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Binbin, Mu, Qitian, Zhu, Huiling, Wang, Yi, Zhang, Yi, Xu, Kaihong, Sheng, Lixia, Ouyang, Guifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
3600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902271/
https://www.ncbi.nlm.nih.gov/pubmed/29620650
http://dx.doi.org/10.1097/MD.0000000000010294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902271/
https://www.ncbi.nlm.nih.gov/pubmed/29620650
http://dx.doi.org/10.1097/MD.0000000000010294

Ejemplares similares